Skip to main content
Jeffrey Drazen, MD, Pulmonology, Boston, MA

JeffreyMarkDrazenMD

Pulmonology • Boston, MA

Critical Care Medicine, Pleural Disease

Parker B. Francis Distinguished Professor of Medicine, Brigham and Women's Hospital

Join to view full profile

Dr. Drazen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Drazen's full profile

Already have an account?

  • Office

    725 Albany St
    Shapiro 9, Suite B
    Boston, MA 02118
    Phone+1 617-638-7480
    Fax+1 617-638-7486

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1972 - 1977
  • Massachusetts General Hospital/BIDMC/Harvard Medical School
    Massachusetts General Hospital/BIDMC/Harvard Medical SchoolFellowship, Pulmonary Disease and Critical Care Medicine, 1974 - 1976
  • Harvard Medical School
    Harvard Medical SchoolClass of 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - Present
  • MA State Medical License
    MA State Medical License 1973 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2003
  • Elected Member The American Society for Clinical Investigation, 1982
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Authored Content

  • Learning from a Trial Stopped by a Data and Safety Monitoring BoardMay 2018
  • Learning from a Trial Stopped by a Data and Safety Monitoring BoardMay 2018
  • Making Sense of Triple Inhaled Therapy for COPDApril 2018

Press Mentions

  • Burdensome Therapy for Severe Hypoxemia in COPD Patients Is Overkill, Trial Says
    Burdensome Therapy for Severe Hypoxemia in COPD Patients Is Overkill, Trial SaysSeptember 10th, 2024
  • Kahun Secures $8Million Round for Its ‘XAI’ Engine for Clinical Reasoning
    Kahun Secures $8Million Round for Its ‘XAI’ Engine for Clinical ReasoningSeptember 30th, 2022
  • I’ve Worked with Robert Califf. He Is the Leader the FDA Needs
    I’ve Worked with Robert Califf. He Is the Leader the FDA NeedsNovember 2nd, 2021
  • Join now to see all

Grant Support

  • Mechanical Stress As A Stimulus For Airway RemodelingNational Heart, Lung, And Blood Institute2007–2011
  • Conference On Rethinking The Pathogenesis Of AsthmaNational Institute Of Allergy And Infectious Diseases2002
  • Zileuton, 5 Lipoxygenase Inhibitor, In Chronic Obstructive Pulmonary DiseaseNational Center For Research Resources2000–2002
  • Daily Variation In Exhaled Nitric OxideNational Center For Research Resources1998–2002
  • Nitric Oxide As An Indicator And Mediator Of Airway InflammationNational Heart, Lung, And Blood Institute1996–2001
  • Core--StatisticalNational Heart, Lung, And Blood Institute1996–2001
  • Mechanical Stress As Stimulus For Airway Wall RemodelingNational Heart, Lung, And Blood Institute1999–2000
  • Asthma Clinical Research NetworkNational Heart, Lung, And Blood Institute1998–2000
  • Genetics Variation In 5lo Product ProductionNational Heart, Lung, And Blood Institute1999
  • Inflammatory Events Initiating And Perpetuating AsthmaNational Heart, Lung, And Blood Institute1996–1999
  • Integrated Training In Respiratory ResearchNational Heart, Lung, And Blood Institute1993–1999
  • Smoking And Respiratory Complications Of HIV In WomenNational Heart, Lung, And Blood Institute1993–1997
  • Informative Studies In Clinical AsthmaNational Heart, Lung, And Blood Institute1993–1997
  • Peptidase Regulation Of Neuropeptide BronchoconstrictionNational Heart, Lung, And Blood Institute1993–1996
  • Functional Implications Of Altering Pulmonary MAST CellsNational Heart, Lung, And Blood Institute1989–1993
  • Differential Response To The Cysteinyl LeukotrienesNational Heart, Lung, And Blood Institute1989–1993
  • Respiratory ResearchNational Heart, Lung, And Blood Institute1990–1992
  • Peptidase Regulation Of Substance P BronchoconstrictionNational Heart, Lung, And Blood Institute1988–1992
  • Non-Uniform Ventilatory MechanicsNational Heart, Lung, And Blood Institute1985–1988
  • Effects Of Chemical Mediators In Animal ModelsNational Heart, Lung, And Blood Institute1985–1988

Dr. Jeffrey Drazen, Dr. Jeffrey Drazen, MD, Dr. J Drazen, Dr. Jeffrey Mark Drazen